Jason Adair sold $726K of Liquidia (LQDA)

Executed Aug 28 2025, disclosed Sep 2 2025, 5 days later.

Value, as filed

$726K

26,057 sh × $27.86

Executed

Aug 28 2025

the trade date, as filed

Disclosed

Sep 2 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JA Jason Adair Chief Business Officer profile →

Jason Adair (Chief Business Officer) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $5.1M of LQDA (73,631 sh across 2 lots, as filed), executed Aug 21.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 102 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jason Adair in LQDA

LQDASALE Liquidia Corporation $208K
7,301 sh × $28.48
Exec Oct 12
Filed Oct 13 · 7:58 PM ET LQDASALE Liquidia Corporation $5.1M
73,631 sh across 2 lots
Exec Aug 21
Filed Aug 25 · 4:30 PM ET LQDASALE Liquidia Corporation $522K
7,301 sh × $71.52
Exec Jul 13
Filed Jul 14 · 8:05 PM ET LQDASALE Liquidia Corporation $280K
7,301 sh × $38.37
Exec Apr 13
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation $507K
13,548 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET LQDASALE Liquidia Corporation $1.1M
35,656 sh × $30.03
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET